Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance

被引:55
作者
Esteghamati, Alireza [1 ]
Ashraf, Haleh [1 ]
Esteghamati, Abdoul-Reza [2 ]
Meysamie, Alipasha [3 ]
Khalilzadeh, Omid [1 ]
Nakhjavani, Manouchehr [1 ]
Abbasi, Mehrshad [1 ]
机构
[1] Univ Tehran Med Sci, Vali asr Hosp, Endocrinol & Metab Res Ctr, Tehran 1419733147, Iran
[2] Iran Univ Med Sci, Fac Med, Tehran, Iran
[3] Univ Tehran Med Sci, Fac Med, Dept Community & Prevent Med, Tehran 1419733147, Iran
关键词
Insulin resistance; HOMA-IR; Cut-off; Metabolic syndrome; ATPIII; IDF; INTERNATIONAL-DIABETES-FEDERATION; GLUCOSE-TOLERANCE; URBAN-POPULATION; PREVALENCE; CRITERIA; OBESITY; PLASMA; QUANTIFICATION; IDENTIFICATION; HYPERTENSION;
D O I
10.1016/j.diabres.2009.03.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
We assessed the threshold of homeostasis model assessment (HOMA) values to determine insulin resistance (IR) in a sample of Iranians and examined the associations of IR with metabolic syndrome (MetS). Study comprised 1327 non-diabetic and non-hypertensive subjects (438 men, 838 women; aged 20-77 years) incurred in four different locations (Tehran, Iran), 2005-2008. Lower limit of the top quintile of HOMA values in subjects without any metabolic abnormality was considered as the threshold of IR. This threshold was 1.8 (1.7 men; 1.8 women). Overall, 41.1% (36.3% men; 41.5% women) of subjects had IR. HOMA cut-off to determine MetS was 1.95 for ATPIII definition, and 1.85 for IDF. IR associated MetS (ATPIII: odds ratio (OR) = 2.9, 95% CI = 2.2-3.9, p < 0.05; IDF: OR = 2.94, 95% CI: 2.3-3.8, p < 0.05). Sensitivity of MetS to detect IR was 22.4% for IDF and 36.2% for ATPIII criteria. In multivariate models, HOMA was predicted by waist circumference, and inversely by age and serum HDL-cholesterol. In this study, the cut point of HOMA to detect IR was lower than other populations. IR is an unyielding correlate of MetS; but definitions of MetS are insensitive measures of IR in our population. (C) 2009 Elsevier Ireland Ltd. All rights reserved
引用
收藏
页码:279 / 287
页数:9
相关论文
共 38 条
[1]
[Anonymous], IDF CONS WORLDW DEF
[2]
Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population [J].
Ascaso, JF ;
Romero, P ;
Real, JT ;
Priego, A ;
Valdecabres, C ;
Carmena, R .
MEDICINA CLINICA, 2001, 117 (14) :530-533
[3]
Ascott-Evans B H, 2005, SADJ, V60, P127
[4]
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study [J].
Azizi, F ;
Salehi, P ;
Etemadi, A ;
Zahedi-Asl, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :29-37
[5]
Balkau B, 1999, DIABETIC MED, V16, P442
[6]
RELATIONSHIP BETWEEN DEGREE OF OBESITY AND INVIVO INSULIN ACTION IN MAN [J].
BOGARDUS, C ;
LILLIOJA, S ;
MOTT, DM ;
HOLLENBECK, C ;
REAVEN, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (03) :E286-E291
[7]
Prevalence of insulin resistance in metabolic disorders - The Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Targher, G ;
Alberiche, M ;
Bonadonna, RC ;
Muggeo, M .
DIABETES, 1998, 47 (10) :1643-1649
[8]
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome [J].
Bray, GA ;
Bellanger, T .
ENDOCRINE, 2006, 29 (01) :109-117
[9]
Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome [J].
Cheal, KL ;
Abbasi, F ;
Lamendola, C ;
McLaughlin, T ;
Reaven, GM ;
Ford, ES .
DIABETES, 2004, 53 (05) :1195-1200
[10]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497